G01N 2333/7456
Factor v
Official title: Factor V
G01N2333/7456 (Factor v) appears on 6 US grants and 12 published applications in this corpus.
Search patents in G01N- Granted patents
- 6
- Published applications
- 12
- Assignees
- 9
- Inventors
- 28
- Latest grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas19 Mar 2024US 11,933,785 B2Wisconsin Alumni Research Foundation
- Sensors and methods for detecting diseases caused by a single point mutation22 Sep 2015US 9,140,707 B2University of Louisville Research Foundation, Inc.
- Compositions, kit and one-step method for monitoring compounds having anti-factor Xa and/or anti factor IIa activities13 Nov 2007US 7,294,479 B2
- Hematological assay7 Feb 2006US 6,994,984 B2Pentapharm AG
- Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state18 Jul 2000US 6,090,570 ADade Behring Marburg GmbH
- Assessment and detection of portal vein thrombosis in chronic liver disease and staging thereof3 Apr 2025US 2025/0110136 A1University of Cincinnati
- Quantification method for modified hdl, and analysis reagent for use in same method14 Sep 2023US 2023/0288437 A1
- Methods for Detection, Staging, and Surveillance of Colorectal Adenomas and Carcinomas3 Oct 2019US 2019/0302120 A1Wisconsin Alumni Research Foundation
- Diagnostic methods and compositions for treatment of cancer26 Feb 2015US 2015/0056190 A1Genentech, Inc.
- Sensors and methods for detecting diseases caused by a single point mutation12 Feb 2009US 2009/0042210 A1University of Louisville Research Foundation, Inc.
Most cited
By later US patents
- Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state10US 6,090,570 ADade Behring Marburg GmbH · 2000
- Calibrator for use in test methods for detecting a defective coagulation factor V5US 5,753,510 ABehring Diagnostics GmbH · 1998
- Hematological assay4US 6,994,984 B2Pentapharm AG · 2006
- Compositions, kit and one-step method for monitoring compounds having anti-factor Xa and/or anti factor IIa activities1US 7,294,479 B22007